News
Events
NEW
Research
NEW
Talk to Us
FEEDBACK
Loading…
Marksans Pharma's Relonchem gets UK marketing authorization for Gabapentin oral solution | Bullu
MARKSANS
Marksans Pharma's Relonchem gets UK marketing authorization for Gabapentin oral solution
Source
|
03:57 15 May 25
regulatory filings
product launches
Marksans Pharma Limited announces that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for Gabapentin 50 mg/ml oral solution.
Subscribe
Ask Bullu
More Latest News